- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有410家主力机构披露2024-12-31报告期持股数据，持仓量总计10.31亿股，占流通A股53.24%
- 波段诊断：
-
技术面诊股
诊断结果：4.0技术面打败了41%的股票
技术面评分前10的股票
近期的平均成本为18.52元。
平均成本
近期的平均成本为18.52元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.52","date":1744881089,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑赢行业平均水平。
[{"date":"2025.04.18","stock":"-0.38","trade":"-0.37","ind":"-0.11"},{"date":"2025.04.17","stock":"-0.43","trade":"0.74","ind":"0.13"},{"date":"2025.04.16","stock":"0.65","trade":"-1.23","ind":"0.26"},{"date":"2025.04.15","stock":"-0.21","trade":"0.11","ind":"0.15"},{"date":"2025.04.14","stock":"-0.11","trade":"1.30","ind":"0.76"},{"date":"2025.04.11","stock":"-0.32","trade":"-0.33","ind":"0.45"},{"date":"2025.04.10","stock":"0.00","trade":"1.99","ind":"1.16"},{"date":"2025.04.09","stock":"1.14","trade":"1.27","ind":"1.31"},{"date":"2025.04.08","stock":"3.88","trade":"1.75","ind":"1.58"},{"date":"2025.04.07","stock":"-6.02","trade":"-10.73","ind":"-7.34"},{"date":"2025.04.03","stock":"0.16","trade":"0.20","ind":"-0.24"},{"date":"2025.04.02","stock":"-0.47","trade":"0.05","ind":"0.05"},{"date":"2025.04.01","stock":"2.43","trade":"2.74","ind":"0.38"},{"date":"2025.03.31","stock":"-2.93","trade":"-1.80","ind":"-0.46"},{"date":"2025.03.28","stock":"-1.60","trade":"-1.13","ind":"-0.67"},{"date":"2025.03.27","stock":"2.26","trade":"0.27","ind":"0.15"},{"date":"2025.03.26","stock":"-0.58","trade":"0.06","ind":"-0.04"},{"date":"2025.03.25","stock":"0.74","trade":"1.13","ind":"-0.00"},{"date":"2025.03.24","stock":"-0.68","trade":"-1.69","ind":"0.15"},{"date":"2025.03.21","stock":"-0.73","trade":"-1.72","ind":"-1.29"},{"date":"2025.03.20","stock":"-0.10","trade":"-0.71","ind":"-0.51"}]
上海医药,上证指数,医药商业指数
压力支撑
该股压力位为18.50元，支撑位为18.41元。
[{"text":"\u538b\u529b\u4f4d","value":"18.50","date":1744905600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.41","date":1744905600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.6资金面打败了87%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月18日 20:40
| 机构今日流向(万元) | -761.09 | 机构5日流向(万元) | -2216.20 |
| 机构10日流向(万元) | -3710.52 | 机构20日流向(万元) | -8385.37 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少4116.56万股，其中基金净减仓21家，主力净增仓14家，暂未发现中长期投资价值。
截止2024-12-31，共410家主力机构（基金407家，一般法人3家），持仓量总计103080.47万股，占流通A股53.24%
其中，基金持仓与2024-06-30相比：
增仓：102家 ，增持 2883.10万股
减仓：123家 ，减持 3310.49万股
新出现在主力名单中：159家 ，持有2970.32万股
从主力名单中消失：145家 ，原持有6577.86万股
其中，基金持仓与2024-06-30相比：
增仓：102家 ，增持 2883.10万股
减仓：123家 ，减持 3310.49万股
新出现在主力名单中：159家 ，持有2970.32万股
从主力名单中消失：145家 ，原持有6577.86万股
消息面诊股
诊断结果：5.6消息面打败了54%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 推动行业健康发展，上海发布医药企业防范商业贿赂案例
2025-04-18 - 上海医药：4月17日获融资买入1788.40万元
2025-04-18 - 并购基金频现 医药等行业受关注
2025-04-18 - 单笔最高近45亿！大批头部药企抛售资产
2025-04-17 - 45亿注射剂市场，华润、国药、齐鲁等30多家药企激
2025-04-17 - 上海医药：4月16日获融资买入486.47万元，占
2025-04-17 - 上海医药：4月15日获融资买入482.76万元
2025-04-16 - 上海医药：4月14日获融资买入607.78万元
2025-04-15 - 上海医药：参与设立生物医药并购基金完成私募投资基金
2025-04-14 - 上海医药集团股份有限公司收购上海和黄药业有限公司股
2025-04-14
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-04-15 |
| 一般消息 | 高管变动 | 不再担任 | 2025-04-08 |
| 一般消息 | 高管变动 | 劳动合同到期后不再续签 | 2025-04-01 |
| 利好 | 分红转增 | 10派2.9元(含税) | 2025-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-28 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-03-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-02-22 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-01-02 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-02 |
| 一般消息 | 高管变动 | 个人原因 | 2024-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-30 |
| 利好 | 分红转增 | 10派0.8元(含税) | 2024-08-27 |
| 一般消息 | 高管变动 | 因工作调动 | 2024-08-05 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2024-06-29 |
| 一般消息 | 高管变动 | 因工作调整 | 2024-05-27 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：5.2行业面打败了69%的股票
医药商业行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2025.04.18","price":"-0.11","value":"-0.37"},{"date":"2025.04.17","price":"0.13","value":"0.74"},{"date":"2025.04.16","price":"0.26","value":"-1.23"},{"date":"2025.04.15","price":"0.15","value":"0.11"},{"date":"2025.04.14","price":"0.76","value":"1.30"},{"date":"2025.04.11","price":"0.45","value":"-0.33"},{"date":"2025.04.10","price":"1.16","value":"1.99"},{"date":"2025.04.09","price":"1.31","value":"1.27"},{"date":"2025.04.08","price":"1.58","value":"1.75"},{"date":"2025.04.07","price":"-7.34","value":"-10.73"},{"date":"2025.04.03","price":"-0.24","value":"0.20"},{"date":"2025.04.02","price":"0.05","value":"0.05"},{"date":"2025.04.01","price":"0.38","value":"2.74"},{"date":"2025.03.31","price":"-0.46","value":"-1.80"},{"date":"2025.03.28","price":"-0.67","value":"-1.13"},{"date":"2025.03.27","price":"0.15","value":"0.27"},{"date":"2025.03.26","price":"-0.04","value":"0.06"},{"date":"2025.03.25","price":"-0.00","value":"1.13"},{"date":"2025.03.24","price":"0.15","value":"-1.69"},{"date":"2025.03.21","price":"-1.29","value":"-1.72"},{"date":"2025.03.20","price":"-0.51","value":"-0.71"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 益丰药房 | 12.17% | 0.18% | 5.3分 |
| 2 | 大参林 | 10.92% | -0.35% | 5.4分 |
| 3 | 南京医药 | -1.19% | 4.63% | 5.2分 |
| 4 | 一心堂 | -3.15% | 1.81% | 4.5分 |
| 5 | 上海医药 | -3.54% | -0.48% | 5.4分 |
| 6 | 国药股份 | -4.44% | -0.65% | 4.6分 |
| 8 | 英特集团 | -5.22% | 2.78% | 5.6分 |
| 10 | 重药控股 | -5.83% | 0.41% | 5.0分 |
| 12 | 国药一致 | -6.59% | 0.16% | 5.1分 |
| 14 | 浙江震元 | -6.93% | 1.32% | 4.9分 |
| 16 | 瑞康医药 | -7.57% | 0.72% | 4.8分 |
| 18 | 柳药集团 | -9.58% | 0.66% | 4.6分 |
| 20 | 华人健康 | -9.72% | 0.91% | 4.3分 |
| 22 | 健之佳 | -9.96% | 0.40% | 3.9分 |
| 24 | 达嘉维康 | -11.68% | 0.77% | 4.6分 |
| 26 | 药易购 | -12.79% | 1.20% | 4.3分 |
| 28 | 合富中国 | -13.57% | 1.43% | 4.1分 |
| 30 | 润达医疗 | -20.89% | -3.85% | 3.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 14/72 ， 18/72。
[{"date":"2024-09-30","value":"5.82","vol":"5.85"},{"date":"2024-06-30","value":"4.25","vol":"4.44"},{"date":"2024-03-31","value":"2.23","vol":"2.30"},{"date":"2023-12-31","value":"5.56","vol":"7.23"},{"date":"2023-09-30","value":"5.60","vol":"7.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.82 | 4.25 | 2.23 | 5.56 | 5.60 |
| 行业(%) | 5.85 | 4.44 | 2.30 | 7.23 | 7.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"11.06","vol":"17.89"},{"date":"2024-06-30","value":"11.60","vol":"17.84"},{"date":"2024-03-31","value":"11.44","vol":"17.80"},{"date":"2023-12-31","value":"12.04","vol":"17.83"},{"date":"2023-09-30","value":"12.13","vol":"18.09"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
11.06 | 11.60 | 11.44 | 12.04 | 12.13 |
| 行业(%) | 17.89 | 17.84 | 17.80 | 17.83 | 18.09 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/72 ， 9/72。
[{"date":"2024-09-30","value":"6.14","vol":"2.06"},{"date":"2024-06-30","value":"5.14","vol":"1.88"},{"date":"2024-03-31","value":"5.93","vol":"4.80"},{"date":"2023-12-31","value":"12.21","vol":"4.27"},{"date":"2023-09-30","value":"13.11","vol":"6.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.14 | 5.14 | 5.93 | 12.21 | 13.11 |
| 行业(%) | 2.06 | 1.88 | 4.80 | 4.27 | 6.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"6.78","vol":"-50.40"},{"date":"2024-06-30","value":"12.72","vol":"-17.67"},{"date":"2024-03-31","value":"1.62","vol":"3.54"},{"date":"2023-12-31","value":"-32.92","vol":"2.19"},{"date":"2023-09-30","value":"-21.13","vol":"10.40"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
6.78 | 12.72 | 1.62 | -32.92 | -21.13 |
| 行业(%) | -50.40 | -17.67 | 3.54 | 2.19 | 10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 11/72 ， 16/72。
[{"date":"2024-09-30","value":"0.96","vol":"0.89"},{"date":"2024-06-30","value":"0.64","vol":"0.60"},{"date":"2024-03-31","value":"0.33","vol":"0.31"},{"date":"2023-12-31","value":"1.27","vol":"1.24"},{"date":"2023-09-30","value":"0.96","vol":"0.91"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.96 | 0.64 | 0.33 | 1.27 | 0.96 |
| 行业(次) | 0.89 | 0.60 | 0.31 | 1.24 | 0.91 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"5.03","vol":"4.52"},{"date":"2024-06-30","value":"3.43","vol":"3.08"},{"date":"2024-03-31","value":"1.76","vol":"1.58"},{"date":"2023-12-31","value":"6.44","vol":"6.32"},{"date":"2023-09-30","value":"4.99","vol":"4.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
5.03 | 3.43 | 1.76 | 6.44 | 4.99 |
| 行业(次) | 4.52 | 3.08 | 1.58 | 6.32 | 4.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"3.23","vol":"4.01"},{"date":"2024-06-30","value":"8.65","vol":"6.46"},{"date":"2024-03-31","value":"-7.80","vol":"-3.83"},{"date":"2023-12-31","value":"4.67","vol":"10.23"},{"date":"2023-09-30","value":"1.02","vol":"2.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.23 | 8.65 | -7.80 | 4.67 | 1.02 |
| 行业 | 4.01 | 6.46 | -3.83 | 10.23 | 2.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.12","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.25","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.12 | - | 1.25 | - |
| 行业 | 0.00 | 0.77 | 0.00 | 1.02 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/72 ， 3/72。
[{"date":"2024-09-30","value":"1.34","vol":"1.47"},{"date":"2024-06-30","value":"1.33","vol":"1.49"},{"date":"2024-03-31","value":"1.34","vol":"1.51"},{"date":"2023-12-31","value":"1.33","vol":"1.51"},{"date":"2023-09-30","value":"1.34","vol":"1.48"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.34 | 1.33 | 1.34 | 1.33 | 1.34 |
| 行业 | 1.47 | 1.49 | 1.51 | 1.51 | 1.48 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.02","vol":"1.04"},{"date":"2024-06-30","value":"1.02","vol":"1.06"},{"date":"2024-03-31","value":"1.00","vol":"1.09"},{"date":"2023-12-31","value":"0.99","vol":"1.07"},{"date":"2023-09-30","value":"1.00","vol":"1.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.02 | 1.02 | 1.00 | 0.99 | 1.00 |
| 行业 | 1.04 | 1.06 | 1.09 | 1.07 | 1.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 15/72 ， 13/72。
[{"date":"2024-09-30","value":"62.83","vol":"61.64"},{"date":"2024-06-30","value":"62.85","vol":"61.18"},{"date":"2024-03-31","value":"62.25","vol":"61.00"},{"date":"2023-12-31","value":"62.11","vol":"60.66"},{"date":"2023-09-30","value":"62.40","vol":"61.05"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
62.83 | 62.85 | 62.25 | 62.11 | 62.40 |
| 行业(%) | 61.64 | 61.18 | 61.00 | 60.66 | 61.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.98","vol":"2.19"},{"date":"2024-06-30","value":"1.99","vol":"2.15"},{"date":"2024-03-31","value":"1.93","vol":"2.15"},{"date":"2023-12-31","value":"1.92","vol":"2.12"},{"date":"2023-09-30","value":"1.94","vol":"2.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.98 | 1.99 | 1.93 | 1.92 | 1.94 |
| 行业(%) | 2.19 | 2.15 | 2.15 | 2.12 | 2.07 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 西部证券 | 2025-04-09 | 买入 | |
| 东吴证券 | 2025-04-01 | 买入 | |
| 浙商证券 | 2025-04-01 | 买入 | 买入 |
| 平安证券 | 2025-03-31 | 增持 | 增持 |
| 中信证券 | 2025-03-31 | 买入 | |
| 中信建投证券 | 2025-03-31 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"50.93","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"56.17","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"37.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"45.53","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"51.65","blueLineValue":"1.39","type":"YC"}]